Controversial Alzheimer’s drug accounts for half of Medicare B premium hike – New York Post

A controversial new Alzheimer’s drug is driving one of the largest increases in Medicare “Part B” premiums.
The standard outpatient premium for the senior healthcare program will leap by $21.60 a mo… [+1738 zCode System Review]

Leave a Reply

Your email address will not be published. Required fields are marked *